Hypophosphatemia during continuous veno-venous hemofiltration is associated with mortality in critically ill patients with acute kidney injury

Critical Care

Volumn 17, Issue 5, 2013, Pages

  Yang, Yi ^a   Zhang, Ping ^a   Cui, Yu ^a   Lang, Xia B ^a   Yuan, Jing ^a   Jiang, Hua ^a   Lei, Wen H ^a   Lv, Rong ^a   Zhu, Yi L ^a   Lai, En Y ^b,c   Chen, Jiang H ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHORUS;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; COHORT ANALYSIS; CONTINUOUS HEMOFILTRATION; CRITICALLY ILL PATIENT; FEMALE; HUMAN; HYPOPHOSPHATEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; CRITICAL ILLNESS; HEMOFILTRATION; INTENSIVE CARE UNIT; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME; TRENDS;

ACUTE KIDNEY INJURY; CRITICAL ILLNESS; FEMALE; HEMOFILTRATION; HUMANS; HYPOPHOSPHATEMIA; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84884226329     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12900     Document Type: Article

References (26)

1. Rosen GH, Boullata JI, O'Rangers EA, Enow NB, Shin B. Intravenous phosphate repletion regimen for critically ill patients with moderate hypophosphatemia. Crit Care Med 1995, 23:1204-1210. 10.1097/00003246-199507000-00009, 7600828.
2. Weisinger JR, Bellorín-Font E. Magnesium and phosphorus. Lancet 1998, 352:391-396. 10.1016/S0140-6736(97)10535-9, 9717944.
3. Håglin L, Burman LA, Nilsson M. High prevalence of hypophosphatemia amongst patients with infectious diseases: a retrospective study. J Intern Med 1999, 246:45-52. 10.1046/j.1365-2796.1999.00540.x, 10447224.
4. Miller DW, Slovis CM. Hypophosphatemia in the emergency department therapeutics. Am J Emerg Med 2000, 18:457-461.
5. Barak V, Schwartz A, Kalickman I, Nisman B, Gurman G, Shoenfeld Y. Prevalence of hypophosphatemia in sepsis and infection: the role of cytokines. Am J Med 1998, 104:40-47. 10.1016/S0002-9343(97)00275-1, 9528718.
6. Geerse DA, Bindels AJ, Kuiper MA, Roos AN, Spronk PE, Schultz MJ. Treatment of hypophosphatemia in the intensive care unit: a review. Crit Care 2010, 14:R147. 10.1186/cc9215, 2945130, 20682049.
7. Aubier M, Murciano D, Lecocguic Y, Viires N, Jacquens Y, Squara P, Pariente R. Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. N Engl J Med 1985, 313:420-424. 10.1056/NEJM198508153130705, 3860734.
8. Fiaccadori E, Coffrini E, Fracchia C, Rampulla C, Montagna T, Borghetti A. Hypophosphatemia and phosphorus depletion in respiratory and failure due to COPD. Chest 1994, 105:1392-1398. 10.1378/chest.105.5.1392, 8181325.
9. Subramanian R, Khardori R. Severe hypophosphatemia: pathophysiologic implications, clinical presentations, and treatment. Medicine (Baltimore) 2000, 79:1-8.
10. Ognibene A, Ciniglio R, Grifenstein A, Jarjoura D, Cugino A, Blend D, Whittier F. Ventricular tachycardia in acute myocardial infarction: the role of hypophosphatemia. South Med J 1994, 87:65-69. 10.1097/00007611-199401000-00014, 7506845.
11. Michell AW, Burn DJ, Reading PJ. Central pontine myelinolysis temporally related to hypophosphataemia. J Neurol Neurosurg Psychiatry 2003, 74:820. 10.1136/jnnp.74.6.820, 1738472, 12754365.
12. Falcone N, Compagnoni A, Meschini C, Perrone C, Nappo A. Central pontine myelinolysis induced by hypophosphatemia following Wernicke's encephalopathy. Neurol Sci 2004, 24:407-410. 10.1007/s10072-003-0197-9, 14767687.
13. Chung PY, Sitrin MD, Te HS. Serum phosphorus levels predict clinical outcome in fulminant hepatic failure. Liver Transpl 2003, 9:248-253. 10.1053/jlts.2003.50053, 12619021.
14. Shor R, Halabe A, Rishver S, Tilis Y, Matas Z, Fux A, Boaz M, Weinstein J. Severe hypophosphatemia in sepsis as a mortality predictor. Ann Clin Lab Sci 2006, 36:67-72.
15. Hoffmann M, Zemlin AE, Meyer WP, Erasmus RT. Hypophosphataemia at a large academic hospital in South Africa. J Clin Pathol 2008, 61:1104-1107. 10.1136/jcp.2007.054940, 18820097.
16. Bellomo R, Ronco C. Continuous renal replacement therapy in the intensive care unit. Intensive Care Med 1999, 25:781-789. 10.1007/s001340050953, 10447534.
17. Troyanov S, Geadah D, Ghannoum M, Cardinal J, Leblanc M. Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy. Intensive Care Med 2004, 30:1662-1665.
18. Santiago MJ, López-Herce J, Urbano J, Bellón JM, del Castillo J, Carrillo A. Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children. Kidney Int 2009, 75:312-316. 10.1038/ki.2008.570, 19002217.
19. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S, . RENAL Replacement Therapy Study Investigators Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009, 361:1627-1638. RENAL Replacement Therapy Study Investigators.
20. Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P, . VA/NIH Acute Renal Failure Trial Network Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008, 359:7-20. 2574780, 18492867, VA/NIH Acute Renal Failure Trial Network.
21. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, . ADQI workgroup Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8:R204-R212. 10.1186/cc2872, 522841, 15312219, ADQI workgroup.
22. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, Conference ISD. SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2001, 2003:530-538.
23. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C, . Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813-818. 10.1001/jama.294.7.813, 16106006, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators.
24. Gaasbeek A, Meinders AE. Hypophosphatemia: an update on its etiology and treatment. Am J Med 2005, 118:1094-1101. 10.1016/j.amjmed.2005.02.014, 16194637.
25. Van Wert R, Friedrich JO, Scales DC, Wald R, Adhikari NK, . University of Toronto Acute Kidney Injury Research Group High-dose renal replacement therapy for acute kidney injury: systematic review and meta-analysis. Crit Care Med 2010, 38:1360-1369. University of Toronto Acute Kidney Injury Research Group.
26. Broman M, Carlsson O, Friberg H, Wieslander A, Godaly G. Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy. Acta Anaesthesiol Scand 2011, 55:39-45. 10.1111/j.1399-6576.2010.02338.x, 3015056, 21039362.